IDNA ETF Price & Analysis

Compare

IDNA ETF Chart & Stats

ETF Overview

iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund

The iShares Genomics Immunology and Healthcare ETF (ticker: IDNA) is a pioneering investment vehicle designed to capture the transformative potential within the genomics sector. This ETF offers exposure to a curated portfolio of companies that are at the forefront of genomic advancements, immunology breakthroughs, and innovative healthcare solutions. As a sector-focused fund, IDNA zeroes in on the exciting and rapidly evolving niche of genomic advancements, providing investors with a unique opportunity to participate in the revolutionary changes reshaping the future of medicine and biotechnology. The ETF targets businesses that are leveraging cutting-edge technologies and research to develop novel therapies, diagnostics, and personalized medicine. By investing in IDNA, stakeholders gain access to firms that are driving innovation in areas such as genome sequencing, gene editing, molecular diagnostics, and immunotherapy. This makes IDNA an ideal choice for those looking to invest in the long-term growth potential of a sector that is not only transforming healthcare but also improving lives through scientific discovery and technological progress. Whether you're an investor seeking to diversify your portfolio with a focus on future-driven sectors or someone passionate about the promise of genomic science, the iShares Genomics Immunology and Healthcare ETF provides a compelling avenue for investment. By aligning your financial goals with the groundbreaking work being done in genomics and healthcare, IDNA stands at the intersection of science and opportunity, ready to deliver value in an ever-evolving marketplace.

iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) Fund Flow Chart

iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) 1 year Net Flows: -$13M

IDNA ETF FAQ

What was IDNA’s price range in the past 12 months?
IDNA lowest ETF price was $18.81 and its highest was $25.80 in the past 12 months.
    What is the AUM of IDNA?
    As of Apr 04, 2025 The AUM of IDNA is 105.81M.
      Is IDNA overvalued?
      According to Wall Street analysts IDNA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does IDNA pay dividends?
        IDNA pays a Semiannually dividend of $0.111 which represents an annual dividend yield of 1.18%. See more information on IDNA dividends here
          How many shares outstanding does IDNA have?
          Currently, no data Available
          Which hedge fund is a major shareholder of IDNA?
          Currently, no hedge funds are holding shares in IDNA

          IDNA ETF Smart Score

          For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

          Top 10 Holdings

          Name
          Weight %
          BeiGene Ltd
          6.52%
          GlaxoSmithKline plc (UK)
          5.70%
          Sanofi
          5.68%
          Roche Holding
          5.54%
          AstraZeneca plc
          5.49%
          Takeda Pharmaceutical Co
          5.26%
          Exelixis
          5.15%
          Springworks Therapeutics
          4.74%
          GMAB
          Genmab A/S
          4.39%
          Merck & Company
          4.21%
          Total52.68%
          See All Holdings
          Popular ETFs
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis